Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 29 out of 100. Treatments

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

As a result of multiple phosphorylation, Tau undergoes early conformational changes involving the bending of the intact amino (N)-terminus over the third repeated domain, which in turn was evidenced by positive immunolabeling with the monoclonal antibody Alz-50 [2]. Besides this, ubiquitination was also observed in NFTs composed of D421-truncated Tau, which may indicate that two different pathways of proteolytic processing occur in a single molecule to promote its aggregation and insolubility in the neuronal cytoplasm [7]. In conclusion, this cascade of pathological molecular events happening in the tau protein may correlate better with the neuropathological progression of the disease. After 48 hours of transfection in neuroblastoma cells, we found remarkable alteration of the tubulin cytoskeleton, forming pericentric and perinuclear ring-shaped microtubule bundles [8].

What this study adds

Evidence grade: Low

This laboratory work describes molecular events in the tau protein, including phosphorylation-driven conformational changes and ubiquitination in neurofibrillary tangles, that may correlate better with neuropathological progression of the disease. It also reports altered tubulin cytoskeleton structure in neuroblastoma cells after transfection, which is early cell-based research and not a treatment finding.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

García‐Sierra, F., & Florán, B. (2025). The Cell and Molecular Pathology of Tau Protein in Alzheimer’s Disease. Microscopy and Microanalysis. https://doi.org/10.1093/mam/ozaf048.453

Vancouver

García‐Sierra F, Florán B. The Cell and Molecular Pathology of Tau Protein in Alzheimer’s Disease. Microscopy and Microanalysis. 2025. doi:10.1093/mam/ozaf048.453.

BibTeX

@article{garciasierra2025-c15ceeee,
  author  = {García‐Sierra, Francisco and Florán, Benjamí­n},
  title   = {{The Cell and Molecular Pathology of Tau Protein in Alzheimer’s Disease}},
  journal = {Microscopy and Microanalysis},
  year    = {2025},
  doi     = {10.1093/mam/ozaf048.453},
  url     = {https://doi.org/10.1093/mam/ozaf048.453}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This laboratory work describes molecular events in the tau protein, including phosphorylation-driven conformational changes and ubiquitination in neurofibrillary tangles, that may correlate better with neuropathological progression of the disease. It also reports altered tubulin cytoskeleton structure in neuroblastoma cells after transfection, which is early cell-based research and not a treatment finding.

Study details

How this study scored 29/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 29 of 100.29 of 100 points earned71 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Microscopy and Microanalysis)
Journal's citation record 1 / 4 Microscopy and Microanalysis: journal h-index 95 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Benjamí­n Florán: h-index 34 (OpenAlex, whole career)
Institution's track record 0 / 3 Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional: institution h-index 542 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 29 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Treatments from nearby years

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Treatments

See all studies in Treatments →